Chris Goodman, M.S.
Virgin Health Bank, Director of Operations
Chris Goodman is currently the Director of Operations for Virgin Health Bank
, managing their services in both the UK and Middle East. He graduated from Hofstra University in 1994 with a Masters in Human Cytogenetics. His first position in the cord blood industry was with Cord Blood Registry
, where he eventually became their Director of Processing and Storage for both autologous and allogeneic umbilical cord blood stem cells. Realizing the benefits of stem cells, and the need for better education and industry standardization, Goodman next became an inspector with the accreditation agency FACT
. He continues to actively work in accreditation standards with the agency AABB
, both as an assessor and as a committee member serving on AABB’s Cellular Therapy Accreditation Program Unit. In 2002, Goodman was recruited by Celgene
to become the Director of Operations for their Cellular Therapeutic Division, including the family cord blood bank LifebankUSA
. This division pioneered the technology behind storage of stem cells from the placenta. In 2008, Goodman was recruited by Roche
to oversee their Detection and Chemical Assay development group for their Tissue Diagnostics Division, Ventana Medical Systems
. While there, he focused on the development of globally distributed CE-IVD
diagnostic solutions for the analysis of tissue biopsies. Then, in 2010, Goodman joined Virgin Health Bank. Goodman is their designated individual to work with the Human Tissue Authority
, a mandatory quality standard for cord blood banks operating in the UK. Goodman's passion is networking with all stakeholders to bring better public education and industry regulation to the Middle East.